Literature DB >> 19026607

Direct comparison of bioluminescence-based resonance energy transfer methods for monitoring of proteolytic cleavage.

Helen Dacres1, Mira M Dumancic, Irene Horne, Stephen C Trowell.   

Abstract

Bioluminescence resonance energy transfer (BRET) is a powerful tool for the study of protein-protein interactions and conformational changes within proteins. Two common implementations of BRET are BRET(1) with Renilla luciferase (RLuc) and coelenterazine h (CLZ, lambda(em) approximately 475 nm) and BRET(2) with the substrate coelenterazine 400a (CLZ400A substrate, lambda(em)=395 nm) as the respective donors. For BRET(1) the acceptor is yellow fluorescent protein (YFP) (lambda(em) approximately 535 nm), a mutant of green fluorescent protein (GFP), and for BRET(2) it is GFP(2) (lambda(em) approximately 515 nm). It is not clear from previous studies which of these systems has superior signal-to-background characteristics. Here we directly compared BRET(1) and BRET(2) by placing two different protease-specific cleavage sequences between the donor and acceptor domains. The intact proteins simulate protein-protein association. Proteolytic cleavage of the peptide linker simulates protein dissociation and can be detected as a change in the BRET ratios. Complete cleavage of its target sequence by thrombin changed the BRET(2) ratio by a factor of 28.9+/-0.2 (relative standard deviation [RSD], n=3) and changed the BRET(1) ratio by a factor of 3.05+/-0.07. Complete cleavage of a caspase-3 target sequence resulted in the BRET ratio changes by factors of 15.45+/-0.08 for BRET(2) and 2.00+/-0.04 for BRET(1). The BRET(2) assay for thrombin was 2.9 times more sensitive compared with the BRET(1) version. Calculated detection limits (blank signal+3sigma(b), where sigma(b)=standard deviation [SD] of blank signal) were 53 pM (0.002 U) thrombin with BRET(1) and 15 pM (0.0005 U) thrombin with BRET(2). The results presented here suggest that BRET(2) is a more suitable system than BRET(1) for studying protein-protein interactions and as a potential sensor for monitoring protease activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19026607     DOI: 10.1016/j.ab.2008.10.040

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  12 in total

Review 1.  Probing heterotrimeric G protein activation: applications to biased ligands.

Authors:  Colette Denis; Aude Saulière; Segolene Galandrin; Jean-Michel Sénard; Céline Galés
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  Distinct allostery induced in the cyclic GMP-binding, cyclic GMP-specific phosphodiesterase (PDE5) by cyclic GMP, sildenafil, and metal ions.

Authors:  Kabir H Biswas; Sandhya S Visweswariah
Journal:  J Biol Chem       Date:  2010-12-29       Impact factor: 5.157

3.  Polyhistidine-Tag-Enabled Conjugation of Quantum Dots and Enzymes to DNA Nanostructures.

Authors:  Christopher M Green; Divita Mathur; Kimihiro Susumu; Eunkeu Oh; Igor L Medintz; Sebastián A Díaz
Journal:  Methods Mol Biol       Date:  2022

4.  Auto-luminescent genetically-encoded ratiometric indicator for real-time Ca2+ imaging at the single cell level.

Authors:  Kenta Saito; Noriyuki Hatsugai; Kazuki Horikawa; Kentaro Kobayashi; Toru Matsu-Ura; Katsuhiko Mikoshiba; Takeharu Nagai
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

5.  Mathematical models for quantitative assessment of bioluminescence resonance energy transfer: application to seven transmembrane receptors oligomerization.

Authors:  Luka Drinovec; Valentina Kubale; Jane Nøhr Larsen; Milka Vrecl
Journal:  Front Endocrinol (Lausanne)       Date:  2012-08-28       Impact factor: 5.555

6.  Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.

Authors:  Mohamed Ali Maroui; Sabrina Kheddache-Atmane; Faten El Asmi; Laurent Dianoux; Muriel Aubry; Mounira K Chelbi-Alix
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

7.  Setting Up a Bioluminescence Resonance Energy Transfer High throughput Screening Assay to Search for Protein/Protein Interaction Inhibitors in Mammalian Cells.

Authors:  Cyril Couturier; Benoit Deprez
Journal:  Front Endocrinol (Lausanne)       Date:  2012-09-11       Impact factor: 5.555

8.  An ultrasensitive NanoLuc-based luminescence system for monitoring Plasmodium berghei throughout its life cycle.

Authors:  Mariana De Niz; Rebecca R Stanway; Rahel Wacker; Derya Keller; Volker T Heussler
Journal:  Malar J       Date:  2016-04-21       Impact factor: 2.979

9.  Comparison of static and microfluidic protease assays using modified bioluminescence resonance energy transfer chemistry.

Authors:  Nan Wu; Helen Dacres; Alisha Anderson; Stephen C Trowell; Yonggang Zhu
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

10.  Target engagement and drug residence time can be observed in living cells with BRET.

Authors:  Matthew B Robers; Melanie L Dart; Carolyn C Woodroofe; Chad A Zimprich; Thomas A Kirkland; Thomas Machleidt; Kevin R Kupcho; Sergiy Levin; James R Hartnett; Kristopher Zimmerman; Andrew L Niles; Rachel Friedman Ohana; Danette L Daniels; Michael Slater; Monika G Wood; Mei Cong; Yi-Qiang Cheng; Keith V Wood
Journal:  Nat Commun       Date:  2015-12-03       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.